BR100 Decreased By (-0.47%)
BR30 Decreased By (-0.77%)
KSE100 Decreased By (-0.38%)
KSE30 Decreased By (-0.35%)
AGHA 6.56 Decreased By ▼ -0.11 (-1.65%)
BECO 4.40 Increased By ▲ 0.05 (1.15%)
BML 55.25 Decreased By ▼ -0.92 (-1.64%)
BOP 29.87 Decreased By ▼ -0.25 (-0.83%)
CNERGY 12.70 Decreased By ▼ -0.28 (-2.16%)
CSIL 5.19 Decreased By ▼ -0.12 (-2.26%)
FCCL 51.20 Decreased By ▼ -0.45 (-0.87%)
FFL 14.40 Decreased By ▼ -0.09 (-0.62%)
FNEL 1.18 Decreased By ▼ -0.03 (-2.48%)
KEL 5.99 Decreased By ▼ -0.07 (-1.16%)
KOSM 5.56 Decreased By ▼ -0.28 (-4.79%)
LOTCHEM 26.19 Increased By ▲ 0.02 (0.08%)
MLCF 90.00 Decreased By ▼ -1.23 (-1.35%)
NBP 162.27 Decreased By ▼ -1.92 (-1.17%)
NCPL 52.70 Decreased By ▼ -0.48 (-0.9%)
NPL 58.00 Decreased By ▼ -1.12 (-1.89%)
OGDC 314.00 Increased By ▲ 0.61 (0.19%)
PACE 9.68 Decreased By ▼ -0.09 (-0.92%)
PAEL 34.91 Decreased By ▼ -0.33 (-0.94%)
PIBTL 14.19 Decreased By ▼ -0.52 (-3.54%)
PPL 219.40 Decreased By ▼ -1.96 (-0.89%)
PRL 89.95 Decreased By ▼ -1.27 (-1.39%)
PTC 59.25 Increased By ▲ 0.06 (0.1%)
SSGC 23.23 Decreased By ▼ -0.07 (-0.3%)
TBL 8.68 Decreased By ▼ -0.07 (-0.8%)
TELE 7.38 Decreased By ▼ -0.23 (-3.02%)
TPL 21.10 Decreased By ▼ -0.93 (-4.22%)
TPLP 12.13 Decreased By ▼ -0.43 (-3.42%)
TREET 21.40 Decreased By ▼ -0.33 (-1.52%)
TRG 54.26 Decreased By ▼ -1.53 (-2.74%)
Topic

Moderna vaccines

Moderna testing new COVID-19 vaccine as potential booster shot

Moderna testing new COVID-19 vaccine as potential booster shot

Updated 15 Mar, 2021 09:25pm
  • The early-stage study will assess the safety and immunogenicity of mRNA-1283 at three dose levels, and will be given to healthy adults either as a single dose or in two doses 28 days apart, the company said.
  • Last week, Moderna began dosing the first participants in a study testing its COVID-19 booster vaccine candidates.
EU drugs regulator gives green light to J&J's single-shot COVID-19 vaccine

EU drugs regulator gives green light to J&J's single-shot COVID-19 vaccine

Published 11 Mar, 2021 06:48pm
  • The COVID-19 shot is the fourth to be endorsed for use in the EU after vaccines from Pfizer-BioNTech , AstraZeneca-Oxford University and Moderna, and is recommended for those over 18 years of age.
  • With this latest positive opinion, authorities across the European Union will have another option to combat the pandemic and protect the lives and health of their citizens.
Loading...